Achillion Pharmaceuticals Names General Counsel and SVP of Regulatory Affairs

By 2016-02-08T13:30:00

Achillion Pharmaceuticals has announced the addition of two members to the senior management team, including the appointment of a new general counsel and secretary, and a new senior vice president of regulatory affairs.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership limited time offer

Subscribe now for $365

Our lowest price ($1 per day) for one year.

Annual Membership $499

Full price one year membership.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS
Already a Compliance Week member?